Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).
作者:
DOI
10.1007/s40257-018-0353-x
PMID
29600394
发布时间
2019-11-20
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文